Suptavumab: A Deep Dive into the REGN2222 Monoclonal Antibody REGN2222 is a monoclonal immunoglobulin designed to selectively inhibit IL-18 , a crucial cytokine associated in severe respiratory syndrome https://www.targetmol.com/compound/suptavumab